• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支气管扩张症患儿的肺功能比囊性纤维化患儿差,但却没有得到同样标准的治疗。

Children with bronchiectasis have poorer lung function than those with cystic fibrosis and do not receive the same standard of care.

机构信息

Department of Respiratory Medicine, Sydney Children's Hospital, Randwick, New South Wales, Australia.

School of Women's and Children's Health, Faculty of Medicine, The University of New South Wales, Randwick, New South Wales, Australia.

出版信息

Pediatr Pulmonol. 2019 Dec;54(12):1921-1926. doi: 10.1002/ppul.24491. Epub 2019 Sep 1.

DOI:10.1002/ppul.24491
PMID:31475469
Abstract

BACKGROUND

Children with cystic fibrosis (CF) are routinely managed in a multidisciplinary clinic at tertiary pediatric centers. However, children with bronchiectasis may not be managed in the same way. We sought to compare the management model and clinical outcomes of children with bronchiectasis with children diagnosed with CF, in a single pediatric center.

METHODS

We identified patients with bronchiectasis from hospital medical records at an urban tertiary pediatric hospital and identified a sex- and age-matched CF patient at the same center to compare lung function, nutritional status, frequency of physiotherapy and respiratory physician visits, and number of microbiological samples taken for bacterial culture.

RESULTS

Twenty-two children with bronchiectasis were identified, mean (standard deviation [SD]) age was 11 (3) years. The most common known etiology for bronchiectasis was postinfective (6 of 22) but was unknown in 8 of 22. The cohort with bronchiectasis had poorer lung function (FEV1 mean [SD] percent predicted 78.6 [20.5] vs 94.5 [14.7], P = .005) and had less outpatient reviews by the respiratory physician (P < .001) and respiratory physiotherapist (P < .001) when compared to those with CF. Nutritional parameters did not differ between the groups. Many children (10 of 22, 45%) with bronchiectasis did not have any microbiological respiratory tract samples taken for evaluation.

CONCLUSION

Children with bronchiectasis at this institution have poorer lung function than children with CF, and are deserving of improved multidisciplinary care.

摘要

背景

患有囊性纤维化 (CF) 的儿童通常在三级儿科中心的多学科诊所接受常规管理。然而,患有支气管扩张症的儿童可能无法采用相同的方式进行管理。我们旨在比较单一儿科中心内支气管扩张症患儿和 CF 患儿的管理模式和临床结局。

方法

我们从一家城市三级儿科医院的医院病历中确定了支气管扩张症患者,并在同一中心确定了一名性别和年龄匹配的 CF 患者,以比较肺功能、营养状况、物理治疗和呼吸科医生就诊的频率,以及用于细菌培养的微生物样本数量。

结果

确定了 22 例支气管扩张症患儿,平均(标准差 [SD])年龄为 11(3)岁。支气管扩张症最常见的已知病因是感染后(22 例中的 6 例),但有 8 例病因不明。支气管扩张症组的肺功能较差(FEV1 平均 [SD] 预计百分比 78.6 [20.5] 与 94.5 [14.7],P = .005),并且与 CF 组相比,呼吸科医生(P < .001)和呼吸物理治疗师(P < .001)的门诊就诊次数更少。营养参数在两组之间没有差异。许多(22 例中的 10 例,45%)支气管扩张症患儿没有进行任何用于评估的微生物呼吸道样本采集。

结论

本机构的支气管扩张症患儿的肺功能比 CF 患儿差,应给予更好的多学科治疗。

相似文献

1
Children with bronchiectasis have poorer lung function than those with cystic fibrosis and do not receive the same standard of care.支气管扩张症患儿的肺功能比囊性纤维化患儿差,但却没有得到同样标准的治疗。
Pediatr Pulmonol. 2019 Dec;54(12):1921-1926. doi: 10.1002/ppul.24491. Epub 2019 Sep 1.
2
Does the effect of comprehensive respiratory physiotherapy home-program differ in children with cystic fibrosis and non-cystic fibrosis bronchiectasis?综合性呼吸物理疗法家庭方案对囊性纤维化和非囊性纤维化支气管扩张症患儿的疗效是否不同?
Eur J Pediatr. 2022 Aug;181(8):2961-2970. doi: 10.1007/s00431-022-04509-5. Epub 2022 May 20.
3
A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience.非囊性纤维化支气管扩张症的病因和临床表现综述:一项三级保健经验。
Respir Med. 2018 Apr;137:35-39. doi: 10.1016/j.rmed.2018.02.013. Epub 2018 Feb 24.
4
Three clinically distinct chronic pediatric airway infections share a common core microbiota.三种临床不同的慢性儿科气道感染具有共同的核心微生物群。
Ann Am Thorac Soc. 2014 Sep;11(7):1039-48. doi: 10.1513/AnnalsATS.201312-456OC.
5
Validating chest MRI to detect and monitor cystic fibrosis lung disease in a pediatric cohort.在一个儿科队列中验证胸部磁共振成像用于检测和监测囊性纤维化肺病。
Pediatr Pulmonol. 2016 Jan;51(1):34-41. doi: 10.1002/ppul.23328. Epub 2015 Oct 5.
6
Deviations of body functions and structure, activity limitations, and participation restrictions of the International Classification of Functioning, Disability, and Health model in children with cystic fibrosis and non-cystic fibrosis bronchiectasis.国际功能、残疾和健康分类模式在囊性纤维化和非囊性纤维化支气管扩张症患儿的身体功能和结构、活动受限以及参与受限方面的偏差。
Pediatr Pulmonol. 2020 May;55(5):1207-1216. doi: 10.1002/ppul.24708. Epub 2020 Feb 28.
7
Changing clinical characteristics of non-cystic fibrosis bronchiectasis in children.儿童非囊性纤维化支气管扩张症的临床特征变化。
BMC Pulm Med. 2020 Jun 16;20(1):172. doi: 10.1186/s12890-020-01214-7.
8
Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries.儿童非囊性纤维化支气管扩张症:发展中国家的一个持续存在的问题。
Respiration. 2005 May-Jun;72(3):233-8. doi: 10.1159/000085362.
9
The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.囊性纤维化患儿肺曲霉病的临床表现——初步报告
Dev Period Med. 2015 Jan-Mar;19(1):66-79.
10
Visuomotor reaction time and dynamic balance in children with cystic fibrosis and non-cystic fibrosis bronchiectasis: A case-control study.囊性纤维化与非囊性纤维化支气管扩张症患儿的视动反应时间与动态平衡:病例对照研究。
Pediatr Pulmonol. 2020 Sep;55(9):2341-2347. doi: 10.1002/ppul.24903. Epub 2020 Jun 22.

引用本文的文献

1
Bronchiectasis in Children: A Comparative Analysis of Cystic Fibrosis and Non-Cystic Fibrosis Etiologies Using the Bhalla Score.儿童支气管扩张症:使用巴哈拉评分对囊性纤维化和非囊性纤维化病因的比较分析
Balkan Med J. 2025 Sep 1;42(5):429-439. doi: 10.4274/balkanmedj.galenos.2025.2025-6-247. Epub 2025 Aug 20.
2
Cough in non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症中的咳嗽
ERJ Open Res. 2024 Dec 2;10(6). doi: 10.1183/23120541.00330-2024. eCollection 2024 Nov.
3
Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial.
厄多司坦治疗支气管扩张症患儿和成人的疗效(BETTER 试验):一项多中心、双盲、随机对照试验的研究方案。
BMJ Open Respir Res. 2024 May 7;11(1):e002216. doi: 10.1136/bmjresp-2023-002216.
4
Physiotherapy management of first nations children with bronchiectasis from remote top end communities of the northern territory: a retrospective chart audit.对来自北领地偏远顶端社区的患有支气管扩张症的原住民儿童的物理治疗管理:一项回顾性病历审核
Front Pediatr. 2023 Oct 13;11:1230474. doi: 10.3389/fped.2023.1230474. eCollection 2023.
5
Transition of pediatric patients with bronchiectasis to adult medical care in the Northern Territory: A retrospective chart audit.北领地支气管扩张症儿科患者向成人医疗护理的过渡:一项回顾性病历审核
Front Pediatr. 2023 Apr 28;11:1184303. doi: 10.3389/fped.2023.1184303. eCollection 2023.
6
Quality standards for managing children and adolescents with bronchiectasis: an international consensus.支气管扩张症患儿及青少年管理的质量标准:一项国际共识
Breathe (Sheff). 2022 Sep;18(3):220144. doi: 10.1183/20734735.0144-2022. Epub 2022 Nov 15.
7
Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand.澳大利亚和新西兰胸科学会(TSANZ)关于澳大利亚和新西兰儿童、青少年和成人慢性化脓性肺病和支气管扩张症的立场声明。
Respirology. 2023 Apr;28(4):339-349. doi: 10.1111/resp.14479. Epub 2023 Mar 2.
8
Global research status and trends of bronchiectasis in children from 2003 to 2022: A 20-year bibliometric analysis.2003年至2022年儿童支气管扩张症的全球研究现状与趋势:一项20年的文献计量分析
Front Pediatr. 2023 Feb 3;11:1095452. doi: 10.3389/fped.2023.1095452. eCollection 2023.
9
Assessment of factors and interventions towards therapeutic adherence among persons with non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症患者治疗依从性的影响因素及干预措施评估
ERJ Open Res. 2022 Nov 7;8(4). doi: 10.1183/23120541.00340-2022. eCollection 2022 Oct.
10
Prevalence of chronic respiratory diseases in Aboriginal children: A whole population study.原住民儿童慢性呼吸道疾病的患病率:一项全人群研究。
Pediatr Pulmonol. 2022 Dec;57(12):3136-3144. doi: 10.1002/ppul.26148. Epub 2022 Sep 23.